Emory Team Uncovers Small Molecule that Boosts RNAi Silencing; Effigene to Sell Tech

The compound, enoxacin, has long been used as an antibiotic, but a chemical screening technology developed by Emory University researcher Peng Jin revealed that the drug could also significantly enhance RNAi silencing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.